NKO Flex
Natural health product licensed in Canada
- Other names
- OCEANO3 Flex
- Licence holder
- Biodroga Nutraceuticals Inc.
- NPN or DIN-HM
- 80066218
- Status
- Active licence
- Licence date
- 5 January 2016
- Revision date
- 17 March 2023
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de krill Source : Euphausia superba - en entier Potency : 126 milligramme Phospholipids | 300 milligramme | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 90 milligramme Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 0.3 milligramme Esterified astaxanthin | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 45 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 27 milligramme Docosahexaenoic acid | Not specified | Not calculated |
| Zinc Source : Oxyde de zinc | 15 milligramme | 15,000 µg |
| Strontium Source : Citrate de strontium | 100 milligramme | Not calculated |
Non-medicinal ingredients
Vanilline, Lycopène, Huile de tournesol, Eau purifiée, Glycérine, Curcuma, Poudre de caroube, Cire jaune, Monostéarate de glycéryle, Sorbitol, Gélatine, Lécithine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce pain associated with osteoarthritis. Helps to reduce blood C reactive protein levels, a clinical marker of inflammation. A factor in the maintenance of good health. Helps to prevent vitamin D deficiency. Helps in the development and maintenance of bone and teeth. Helps in the absorption and use of calcium and phosphorus. Helps in connective tissue formation. Helps to prevent zinc deficiency. Helps to support bone mineral density.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80066218
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.